The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Premier Fiscal Services Pvt. Ltd., a promoter of Gennex Laboratories Ltd, has pledged 25,00,000 equity shares (about 1.03% of total share capital) with M/s. Vidya Tradecon Pvt. Ltd. on June 9, 2026, to avail a business loan of Rs. 1.25 crore. The pledge has an expiry date of December 7, 2026, and the pledged shares are valued at Rs. 2.5 crore, giving a 2x security cover. After this pledge, the promoter's total encumbered shares stand at 1,25,00,000 shares, or 5.145% of total share capital and roughly 23.6% of the promoter's own holding. The promoter continues to hold 5,30,38,000 shares, representing 21.83% of Gennex Laboratories.
This is a routine disclosure of a new pledge by the promoter to raise a business loan. The pledge level is well below the 50% promoter-holding threshold, so it does not raise immediate governance red flags. However, retail investors should track any future increase in pledged shares or any invocation, as that could affect promoter control and stock sentiment.